Literature DB >> 35348994

Learning and memory impairment induced by 1,4-butanediol is regulated by ERK1/2-CREB-BDNF signaling pathways in PC12 cells.

Congying Chen1, Lingling Bu1, Huan Liu1, Yifeng Rang1, Huiying Huang1, Xueman Xiao1, Genghua Ou1, Chunhong Liu2.   

Abstract

1,4-butanediol (1,4-BD) is a known γ-hydroxybutyric acid (GHB) precursor which affects the nervous system after ingestion, leading to uncontrolled behavioral consequences. In the present study, we investigated whether 1,4-BD induces oxidative stress and inflammation in PC12 cells and evaluated the toxic effects of 1,4-BD associates with learning and memory. CCK-8 results revealed a dose-effect relationship between the cell viability of PC12 cells and 1,4-BD when the duration of action was 2 h or 4 h. Assay kits results showed that 1,4-BD decreased the levels of Glutathione (GSH), Glutathione peroxidase (GSH-px), Superoxide dismutase (SOD), Acetylcholine (Ach) and increased the levels of Malondialdehyde (MDA), Nitric oxide (NO) and Acetylcholinesterase (AchE). Elisa kits results indicated that 1,4-BD decreased the levels of synaptophysin I (SYN-1), Postsynaptic density protein-95 (PSD-95), Growth associated protein-43 (GAP-43) and increased the levels of Tumor necrosis factor alpha (TNF-α) and Interleukin- 6 (IL-6). RT-PCR results showed that the mRNA levels of PSD-95, SYN-1 and GAP-43 were significantly decreased. The expression of phosphorylation extracellular signal-regulated protein kinase 1/2 (p-ERK1/2), phosphorylation cAMP response element binding protein (p-CREB) and brain-derived neurotrophic factor (BDNF) proteins were significantly decreased in PC12 cells by protein blotting. Overall, these results suggest that 1,4-BD may affect synaptic plasticity via the ERK1/2-CREB-BDNF pathway, leading to Ach release reduction and ultimately to learning and memory impairment. Furthermore, oxidative stress and inflammation induced by 1,4-BD may also result in learning and memory deficits. These findings will enrich the toxicity data of 1.4-BD associated with learning and memory impairment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  1,4-BD; ERK1/2-CREB-BDNF signal pathway; GHB; Learning and memory

Mesh:

Substances:

Year:  2022        PMID: 35348994     DOI: 10.1007/s11011-022-00963-0

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.655


  57 in total

Review 1.  International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function.

Authors:  N G Bowery; B Bettler; W Froestl; J P Gallagher; F Marshall; M Raiteri; T I Bonner; S J Enna
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 2.  BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis.

Authors:  Clive R Bramham; Elhoucine Messaoudi
Journal:  Prog Neurobiol       Date:  2005-06       Impact factor: 11.685

3.  Resuscitative treatments on 1,4-butanediol mortality in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Lawrence S Quang; Timothy J Maher; Gian Luigi Gessa
Journal:  Ann Emerg Med       Date:  2005-12-27       Impact factor: 5.721

4.  Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons.

Authors:  O Arancio; M Kiebler; C J Lee; V Lev-Ram; R Y Tsien; E R Kandel; R D Hawkins
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

5.  Identification and quantitation of 1,4-butanediol in mammalian tissues: an alternative biosynthetic pathway for gamma-hydroxybutyric acid.

Authors:  S A Barker; O C Snead; F Poldrugo; C C Liu; F P Fish; R L Settine
Journal:  Biochem Pharmacol       Date:  1985-05-15       Impact factor: 5.858

Review 6.  GHB, GBL and 1,4-BD addiction.

Authors:  Tibor M Brunt; Jan G C van Amsterdam; Wim van den Brink
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  An overview of gamma-hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results.

Authors:  H Andresen; B E Aydin; A Mueller; S Iwersen-Bergmann
Journal:  Drug Test Anal       Date:  2011-03-04       Impact factor: 3.345

8.  The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.

Authors:  Lowell A Borgen; Richard A Okerholm; Allen Lai; Martin B Scharf
Journal:  J Clin Pharmacol       Date:  2004-03       Impact factor: 3.126

9.  ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons.

Authors:  Mariana Alonso; Jorge H Medina; Lucas Pozzo-Miller
Journal:  Learn Mem       Date:  2004 Mar-Apr       Impact factor: 2.460

10.  Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine.

Authors:  Alan D Brailsford; David A Cowan; Andrew T Kicman
Journal:  J Anal Toxicol       Date:  2012-03       Impact factor: 3.367

View more
  1 in total

Review 1.  Acupuncture Interventions for Alzheimer's Disease and Vascular Cognitive Disorders: A Review of Mechanisms.

Authors:  Kunrui Du; Shaojie Yang; Jingji Wang; Guoqi Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-09-28       Impact factor: 7.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.